; the majority of bone marrow-derived cells (BMDCs) in the angiogenic foci were monocytes/macrophages (Mø), 3 which contribute to vascular repair and angiogenesis. 4 We hypothesized that Eng deficiency in BMDCs causes cerebrovascular abnormalities in mice after VEGF stimulation.
). Notch1 expression in Eng +/− Mø decreased at 100 ng/mL of VEGF treatment compared with WT (P<0.001; Figure 3B ).
Discussion
This is the first demonstration that Eng haploinsufficiency in BMDCs was sufficient to cause cerebrovascular dysplasia in the adult mouse after angiogenic stimulation. The abnormal angiogenic response was associated with altered expression of angiogenesis-related genes in Mø. These findings are consistent with previous work in Eng +/− myocardial infarction mice showing that transfusion of normal, but not hereditary hemorrhagic telangiectasia 1, human mononuclear cells rescued the defect. 4 Transforming growth factor-β, VEGF, and Notch pathways act either synergistically with or antagonistically against each other during angiogenesis in a context-dependent manner. 5 Notch signaling in Mø plays a critical role in angiogenesis and repair. Abrogation of monocytic Notch1 adversely affected repair after myocardial injury. 6 Conditional deletion of Mø Notch1 caused abnormal anastomosis between angiogenic sprouts. 7 Further study is needed to examine whether reduced Notch1 signaling in Eng +/− Mø contributes to a dysplastic phenotype.
VEGF dose-dependent effect on Mø depends on culture conditions. Chemotactic response of human Mø to VEGF peaked at 12 ng/mL and decreased after 40 ng/mL with 2-hour incubation. 8 We found that 50 ng/mL of VEGF upregulated metalloproteinase-9 in murine Mø, whereas neither 10 nor 100 ng/mL had any effect. Possible explanations are as follows: (1) human cells respond to VEGF differently from mouse cells; and (2) various VEGF doses differentially trigger various signaling pathways to regulate diverse monocytic functions. Notch1 is induced by VEGF in arterial ECs. 5 However, its expression in mouse Mø was not affected by VEGF (10-100 ng/mL) in our study, possibly because only a subpopulation of Mø expresses Notch1 during angiogenesis. 7 Growth factors and cytokines produced by BMDCs can affect local angiogenesis via systemic signaling. We showed that the mobilization of metalloproteinase-9-deficient BMDCs into circulation in response to VEGF was reduced, which resulted in less BMDC homing and brain angiogenesis. 9 VEGF may affect Mø polarization by effects on Notch signaling. 10 Further studies should address the indirect/systemic effects of Eng deficiency on the BMDC function and the effect of VEGF on Mø polarization. 
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Eng deficiency in endothelial precursors may also play a role and deserves further study. In tumors, very few endothelial precursors are capable of triggering the angiogenic switch. 11 Furthermore, only a small number of homozygously Engdeleted ECs (≈1%) was sufficient to induce macroscopic cerebrovascular dysplasia after VEGF stimulation. 
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In summary, ≥1 subpopulations of Eng +/− BMDCs are sufficient to induce an abnormal vascular response to brain angiogenic stimulation. Highly relevant to hereditary hemorrhagic telangiectasia 1, it may be possible to envision development of a rescue strategy using BM transplantation therapy. The role of BMDCs in sporadic brain arteriovenous malformations needs further study, because Mø are associated with lesion 13 and endothelial precursors incorporate into the abnormal vascular structures.
14 Consideration should also be given to the role of ENG in other cerebrovascular diseases, such as stroke.
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